Ali Azadi, MD
Urogynecology and Reconstructive Pelvic Surgery · Peoria, AZNPI 1881810224
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 216 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,254, 2.6 times the $864 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in AZ, where the typical reported total is $8,817.
Across 216 payments — averaging $38.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Intuitive Surgical$1K
- Axonics, Inc.$578
- AbbVie$473
- Coloplast$472
- plus $2K from 19 others
Across 33 payments — averaging $3194.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sumitomo Pharma America, Inc.$100K
- Myovant Sciences GmbH$5K
What the payments were for
- Travel & lodging$2263%
- Food & beverage$7,88595%
- Gifts$2263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 60 | $2,001 |
| Boston Scientific | 33 | $1,407 |
| Intuitive Surgical | 13 | $1,079 |
| Axonics, Inc. | 12 | $578 |
| AbbVie(2 entities) | 26 | $473 |
| Coloplast | 15 | $472 |
| Astellas Pharma US Inc | 12 | $472 |
| Caldera Medical, Inc | 14 | $425 |
| Hologic Sales And Service, LLC | 3 | $222 |
| Femselect Inc. | 5 | $189 |
| Sumitomo Pharma America, Inc. | 3 | $168 |
| Applied Medical Resources Corporation | 1 | $149 |
| Davol Inc. | 1 | $132 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Baxter Healthcare | 3 | $121 |
| Coopersurgical, Inc. | 3 | $117 |
| Therapeuticsmd, Inc. | 3 | $46 |
| Channel Medsystems, Inc. | 1 | $33 |
| Johnson & Johnson | 1 | $30 |
| Dilon Technologies, Inc. | 1 | $26 |
| GSK | 1 | $19 |
| Minerva Surgical, Inc | 1 | $16 |
| Abbott | 1 | $15 |
| Myovant Sciences Inc. | 1 | $12 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$1,137
- Da Vinci Surgical System$569
- Bulkamid$442
- Axonics$428
- ALTIS$304
- Solyx SIS System$229
- GelPOINT V-Path$149
- EnPlace$141
- ACESSA PROVU SYSTEM$139
- ARISTA$132
- GENERAL - THERAPIES$129
- Advantage System$127
- CAMZYOS$123
- Veozah$122
- MYFEMBREE$121
- MYRBETRIQ$115
- Desara$112
How this compares
$8,337 in reported general payments places this provider in the 45th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Arizona.
See all urogynecology and reconstructive pelvic surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 186 | $123,569 |
| MyrbetriqMirabegron | 92 | $57,239 |
| PremarinEstrogens, Conjugated | 57 | $25,135 |
| BotoxOnabotulinumtoxina | 15 | $13,232 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 437 | $5,272 |
| Estradiol | 67 | $4,158 |
| Cephalexin | 245 | $3,529 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 606 | $1,667 |
| Methenamine Hippurate | 28 | $1,634 |
| Trimethoprim | 22 | $1,587 |
| Solifenacin Succinate | 42 | $1,425 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $1,374 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $1,265 |
| Clobetasol Propionate | 24 | $881 |
| Ciprofloxacin Hcl | 184 | $846 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $168 | $123,569186 claims |
| Astellas Pharma US IncMyrbetriq | $472 | $57,23992 claims |
| AbbVieBotox | $473 | $13,23215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 24 urogynecology and reconstructive pelvic surgery providers in Arizona.
Other urogynecology and reconstructive pelvic surgery in Peoria
- Polina SawyerPeoria$4K
- Suzette SutherlandScottsdale$354K
- Jennifer KlauschieLitchfield Park$95K
- Gina CliettOro Valley$76K
- Anthony GaddiGilbert$72K
- Felipe VidelaPhoenix$25K
- Kelly KantartzisMesa$21K
- Daniel StonePhoenix$20K
- Mohammad IslamScottsdale$19K
- Peter JeppsonMesa$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.